Mainehealth
Mainehealth was paid $3.18M by Medicaid between Jan 2018 and Dec 2023, across 29 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 36% of everything it billed.
SCARBOROUGH, ME 04074
Next to other Neuromusculoskeletal Medicine & OMM Physician providers in Maine
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,204 | $329K | |
| 2019 | 5,061 | $507K | |
| 2020 | 4,479 | $421K | |
| 2021 | 5,718 | $676K | |
| 2022 | 5,708 | $741K | |
| 2023 | 3,931 | $508K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 36% | 18,741 | 18,080 | $1.15M |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 20% | 868 | 790 | $648K |
| 64483 | 17% | 1,334 | 1,296 | $537K | |
| 62323 | 11% | 1,190 | 1,158 | $337K | |
| 64493 | 8.4% | 627 | 609 | $268K | |
| 62321 | 2.8% | 262 | 257 | $89K | |
| 64642 | 2.5% | 344 | 340 | $78K | |
| 64635 | 2.2% | 70 | 68 | $70K | |
| Q3014 | Telehealth originating site facility fee | <1% | 160 | 159 | $2K |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 178 | 171 | $859.06 |
| 97161 | <1% | 15 | 15 | $672.29 | |
| 64494 | <1% | 341 | 308 | $605.00 |
17 more codes
| 64636 | <1% | 45 | $543.20 | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 66 | $227.24 |
| 72040 | <1% | 13 | $158.19 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,710 | $102.24 |
| 97760 | <1% | 25 | $55.42 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 510 | $27.20 |
| 95886 | <1% | 175 | $19.20 | |
| 64643 | <1% | 92 | $18.80 | |
| 95874 | <1% | 173 | $18.58 | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 15 | $5.02 |
| J3490 | Unclassified drugs | 0% | 463 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 272 | $0.00 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 0% | 1,254 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 58 | $0.00 |
| 76942 | 0% | 57 | $0.00 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0% | 30 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Mainehealth | Portland, ME | $142.72M |
| Mainehealth | Portland, ME | $115.05M |
| Mainehealth | Biddeford, ME | $70.83M |
| Mainehealth | Brunswick, ME | $40.06M |
| Mainehealth | Farmington, ME | $22.62M |
| Mainehealth | Biddeford, ME | $10.89M |
| Mainehealth | Falmouth, ME | $6.54M |
| Mainehealth | Portland, ME | $5.46M |
| Mainehealth | Scarborough, ME | $5.04M |
| Mainehealth | Rockport, ME | $4.34M |
| Mainehealth | Scarborough, ME | $4.16M |
| Mainehealth | Portland, ME | $4.09M |
| Mainehealth | Scarborough, ME | $3.94M |
| Mainehealth | Portland, ME | $3.55M |
| Mainehealth | Waldoboro, ME | $3.43M |
| Mainehealth | Brunswick, ME | $2.77M |
| Mainehealth | Portland, ME | $2.68M |
| Mainehealth | Falmouth, ME | $2.10M |
| Mainehealth | Portland, ME | $1.87M |
| Mainehealth | Cape Elizabeth, ME | $1.82M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.